Resultado de búsqueda
1 de abr. de 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
- S4.1-2
The ACC/AHA Task Force on Clinical Practice Guidelines (Task...
- 2010 Accf/Aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Markers reflective of autonomic nervous system function can...
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
Although the format of our recommendations might resemble...
- 2011 Accf/Aha Guideline for Coronary Artery Bypass Graft Surgery
The American College of Cardiology Foundation (ACCF) and the...
- Correction To
In the article by Heidenreich et al, “2022 AHA/ACC/HFSA...
- Richard W. Nesto
The American Heart Association (AHA) and the American...
- Post–Cardiac Arrest Care
Part 9: post–cardiac arrest care: 2010 American Heart...
- S4.1-2
1 de abr. de 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
1 de abr. de 2022 · 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) now includes 4 medication classes which include sodium-glucose cotransporter-2 inhibitors (SGLT2i).
2 de abr. de 2022 · The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests.
The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests.
Recommendations are provided for patients with HF and iron deficiency, anemia, hypertension, sleep disorders, type 2 diabetes, atrial fibrillation, coronary artery disease, and malignancy. 1) GDMT for HFrEF includes 4 medication classes. GDMT for HFrEF. 2) New recommendations in HFmrEF (LVEF 41-49% Recommendations for HFmrEF.
1 de abr. de 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
